DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015
暂无分享,去创建一个
Stefano Moro | Alberto Cuzzolin | Veronica Salmaso | Mattia Sturlese | M. Sturlese | S. Moro | V. Salmaso | Alberto Cuzzolin
[1] Thomas Stützle,et al. Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..
[2] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[3] Roderick E Hubbard,et al. How well can fragments explore accessed chemical space? A case study from heat shock protein 90. , 2011, Journal of medicinal chemistry.
[4] Anthony M Giannetti,et al. Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. , 2014, Bioorganic & medicinal chemistry letters.
[5] V. Hornak,et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.
[6] M J Harvey,et al. ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale. , 2009, Journal of chemical theory and computation.
[7] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[8] Jun Chen,et al. N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors. , 2010, Bioorganic & medicinal chemistry letters.
[9] Y. N. Kang,et al. Heat Shock Protein 90 Bound to CS319 , 2016 .
[10] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[11] Herbert Waldmann,et al. Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4. , 2015, Angewandte Chemie.
[12] Kevin Chen,et al. Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis. , 2015, ACS medicinal chemistry letters.
[13] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[14] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[15] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[16] Paul Labute,et al. Variability in docking success rates due to dataset preparation , 2012, Journal of Computer-Aided Molecular Design.
[17] M. Congreve,et al. Recent developments in fragment-based drug discovery. , 2008, Journal of medicinal chemistry.
[18] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[19] Gianni Chessari,et al. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency. , 2010, Journal of medicinal chemistry.
[20] K. Gajiwala,et al. Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyri , 2011, Journal of medicinal chemistry.
[21] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[22] Thomas Williams,et al. Gnuplot 4.4: an interactive plotting program , 2010 .
[23] Neal Rosen,et al. Hsp90: a novel target for cancer therapy. , 2006, Current topics in medicinal chemistry.
[24] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[25] Sung-jin Kim,et al. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design. , 2011, Bioorganic & medicinal chemistry letters.
[26] X. Barril,et al. Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone. , 2009, Journal of medicinal chemistry.
[27] M. Czech,et al. Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases , 2016, Trends in Endocrinology & Metabolism.
[28] Richard D. Taylor,et al. Improved protein–ligand docking using GOLD , 2003, Proteins.
[29] Gerhard Klebe,et al. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..
[30] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[31] Stefano Moro,et al. DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations , 2015, Molecules.
[32] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[33] Patricia Rodriguez-Tomé,et al. MMsINC: a large-scale chemoinformatics database , 2008, Nucleic Acids Res..
[34] P. Labute. proteins STRUCTURE O FUNCTION O BIOINFORMATICS Protonate3D: Assignment of ionization , 2013 .
[35] Anthony M Giannetti,et al. Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. , 2014, Journal of medicinal chemistry.
[36] Xavier Barril,et al. rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids , 2014, PLoS Comput. Biol..
[37] Stefano Moro,et al. Bridging Molecular Docking to Membrane Molecular Dynamics To Investigate GPCR-Ligand Recognition: The Human A2A Adenosine Receptor as a Key Study , 2014, J. Chem. Inf. Model..
[38] George Papadatos,et al. ChEMBL web services: streamlining access to drug discovery data and utilities , 2015, Nucleic Acids Res..
[39] T. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..